Evidence map›Paper›PMID 41081991›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Artificial intelligence in clinical microbiology: results from the first National survey by the Italian association of clinical microbiologists.

Alberto Rizzo, Enrico Mensa, Laura Squarzon, Pierangelo Clerici, Riccardo Lucis

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alberto RizzoLaboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, via G. B. Grassi 74, Milan, 20157, Italy. rizzo.alberto@asst-fbf-sacco.it.ORCID http://orcid.org/0000-0001-5999-006X
Enrico MensaComputer Science Department, University of Turin, Turin, 10124, Italy.
Laura SquarzonArtificial Intelligence/Machine Learning in Microbiology Study Group (GLAIMAL) of the Italian Association of Clinical Microbiologists (AMCLI), Milan, 20159, Italy.ORCID http://orcid.org/0000-0002-7479-7310
Pierangelo ClericiItalian Association of Clinical Microbiologists (AMCLI), Milan, 20159, Italy.
Riccardo LucisArtificial Intelligence/Machine Learning in Microbiology Study Group (GLAIMAL) of the Italian Association of Clinical Microbiologists (AMCLI), Milan, 20159, Italy.ORCID http://orcid.org/0009-0007-3730-3936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeArtificial Intelligence (AI) and Machine Learning (ML) are innovative technologies, gathering particular interest in all laboratory settings. The aim of this study was to assess the current state of AI and ML adoption in Italian laboratories of clinical microbiology.

methodsA structured 63-question survey was developed by the AI/ML in Microbiology Study Group and distributed to all members of the Italian Association of Clinical Microbiologists between December 2024 and March 2025. Responses were collected anonymously and analyzed using descriptive statistics analysis.

resultsA total of 163 professionals completed the survey. While 25.4% reported current AI/ML usage-primarily in bacteriology and virology-the majority had limited experience with AI technologies. Only 13.6% of respondents had a good understanding of AI/ML concepts, and 2.5% reported having trained data scientists on staff. Major barriers included lack of trained personnel and insufficient infrastructure. Most participants (99.0%) expressed interest in targeted AI training, and 57.5% showed willingness to collaborate on AI-related initiatives. Large language models (LLMs) were seen as promising, especially for data interpretation, despite low adoption rates.

conclusionThe survey might provide valuable insights to identify priority areas for intervention, guide future training initiatives and develop targeted strategies to promote the adoption of these technologies through a fruitful dialogue with companies and IT professionals.

Indexed as

Artificial IntelligenceFemaleHumansItalyLaboratories, ClinicalMachine LearningMaleMicrobiologySurveys and QuestionnairesArtificial intelligenceClinical microbiologyDigitalizationInfectious diseasesLaboratory diagnosis.Large language model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.